• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Vernalis - Articles and news items

Vernalis acquires US rights to Moxatag

Industry news / 2 October 2015 / Victoria White

Moxatag is a penicillin-class antibacterial indicated for the treatment of tonsillitis and pharyngitis secondary to streptococcus pyogenes…

Twice-daily cough syrup Tuzistra XR launched in the US

Industry news / 8 September 2015 / Victoria White

Tuzistra XR is the only codeine-based extended-release cough cold syrup available to patients and physicians in the United States…

Vernalis completes investment in NCE development pipeline

Industry news / 20 August 2015 / Victoria White

Vernalis has announced results from a Phase II proof-of-concept study of V158866, its fatty acid amide hydrolase (FAAH) inhibitor…